Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of Nodule Allocation.
FUSION iENA
I-124 PET/US for Benign Thyroid Diseases - Blinded, Multicentric Assessment of Augmented Thyroid Work-up Versus Regular Thyroid Diagnostics
1 other identifier
observational
70
1 country
1
Brief Summary
Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedStudy Start
First participant enrolled
April 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedMay 4, 2017
April 1, 2017
2 months
April 20, 2017
May 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic-sonographic nodule allocation
The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale.
1 year
Study Arms (2)
Regular Thyroid Work-up
Nuclear Medicine physicians evaluate up to 34 cases of patients who have received regular thyroid diagnostics. Data and images of patient characteristics, laboratory results, ultrasonography loops and planar 99mTcO4 scintigraphy are provided and the physicians are asked to assign the function (hypo-, iso-, hyperfunctional) to predefined thyroid nodules visible on ultrasonography.
Regular Thyroid Work-up and I-124 PET/US
Nuclear Medicine physicians evaluate up to 34 cases of patients who have received regular thyroid diagnostics and additional I-124 PET/CT, followed by I-124 PET/US (administration of I-124 was not subject of this study). Data and images of patient characteristics, laboratory results, ultrasonography loops, planar 99mTcO4 scintigraphy as well as I-124 PET/US loops are provided and the physicians are asked to assign the function (hypo-, iso-, hyperfunctional) to predefined thyroid nodules visible on ultrasonography.
Interventions
Assessment of preacquired I-124 PET/US by review of anonymous digital case files
Eligibility Criteria
Data of patients with unclear findings on regular thyroid work-up who had received additional I-124-PET/US in our institution.
You may qualify if:
- patients with thyroidal nodules,
- euthyroidism
- Uptake \>0,5% on Tc-99m-pertechnetate- scintigraphy
You may not qualify if:
- thyroid medications in the last 6 months
- Iodine exposition in the last 6 months
- thyroid surgery or radioiodine therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jena University Hospitallead
- GE Healthcarecollaborator
Study Sites (1)
University Hospital Jena
Jena, Thuringia, 07747, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2017
First Posted
April 25, 2017
Study Start
April 26, 2017
Primary Completion
July 1, 2017
Study Completion
April 1, 2018
Last Updated
May 4, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share